The Effect of Different Thawing Rates on Cryopreserved Human Iliac Arteries Allograft's Structural Damage and Mechanical Properties

Introduction The rate of thawing of cryopreserved human iliac arteries allografts (CHIAA) directly affects the severeness of structural changes that occur during this process. Method The experiment was performed on ten CHIAA. The 10% dimethylsulphoxide in 6% hydroxyethyl starch solution was used as the cryoprotectant; all CHIAA were cooled at a controlled rate and stored in the vapor phase of liquid nitrogen (-194°C). Two thawing protocols were tested: (1) placing the CHIAA in a water bath at 37°C, and (2) the CHIAA were thawed in a controlled environment at 5°C. All samples underwent analysis under a scanning electron microscope. Testing of the mechanical properties of the CHIAA was evaluated on a custom-built single axis strain testing machine. Longitudinal and circumferential samples were prepared from each tested CHIAA. Results Ultrastructural analysis revealed that all five CHIAA thawed during the thawing protocol 1 which showed significantly more damage to the subendothelial structures when compared to the samples thawed in protocol 2. Mechanical properties: Thawing protocol 1—longitudinal UTS 2, 53 ± 0, 47 MPa at relative strain 1, 27 ± 0, 12 and circumferential UTS 1, 94 ± 0, 27 MPa at relative strain 1, 33 ± 0, 09. Thawing protocol 2—longitudinal ultimate tensile strain (UTS) 2, 42 ± 0, 34 MPa at relative strain 1, 32 ± 0, 09 and circumferential UTS 1, 98 ± 0, 26 MPa at relative strain 1, 29 ± 0, 07. Comparing UTS showed no statistical difference between thawing methods. Conclusion Despite the significant differences in structural changes of presented thawing protocols, the ultimate tensile strain showed no statistical difference between thawing methods.


Introduction
Vascular infection is a leading cause of morbidity and mortality affecting up to 15% of patients [1]. Cryopreserved arterial allografts (CA) are used as an alternative vascular conduit in the treatment of vascular infection or critical limb ischemia in patients with the absence of autologous saphenous vein, or patients unsuitable for prosthetic graft implantation due to a high risk of reoccurring infection [2]. Despite the need for CA frequent reintervention and poor amputationfree survival, CA are used as the last option in patients where fresh allografts are unavailable [3]. Gilbert et al. published in 1979 the first concept on preserving mechanical properties of CA [4]. In the past two decades, there were significant technical improvements and innovations in tissue cryopreservation minimising the structural damage and preserving functional integrity of vascular allografts [5]. However, minimal progress in thawing protocols of the CA abated the progress in cryopreserving techniques incontrovertibly causing structural damage of CA. Therefore, it is essential to evaluate these structural changes caused by thawing and their effect on CA mechanical properties. To our knowledge, the correlation between structural changes caused by different rates of thawing of CA and their subsequent impact on the mechanical properties has not been reported on human CA.
All the allografts were harvested in the operation theatre in patients that were organ donors and were pronounced "clinically dead" with compliance to the Czech Republic's transplants laws. All experiments were performed in accordance with relevant guidelines and regulations of the Czech Republic.

Allograft Harvest, Processing, and Cryopreservation
Protocol. All human CHIAA were harvested aseptically in deceased donors during multiple organ/tissue harvests performed at operating rooms of organ donor hospitals. Organ preservation solution Celsior (IGL, France) supplemented with gentamycin was used for transport to a tissue bank included in the list of European Union Tissue Establishments under the EUTE Code CZ000427. The grafts were processed as soon as possible after admission and/or input control [2]. Decontamination was performed in an antibiotic cocktail described by van Kats at 37°C for 2 hours [6]. The remnants of antibiotics were washed out by placing the allografts into the 6% hydroxyethyl starch (HES) solution for 20 minutes. Placement of the allografts to the precooled cryoprotectant solution 10% dimethylsulphoxide (DMSO) (WAK Chemie, GMBh, FRG) in 6% HES (Fresenius-Kabi, FRG)) was performed in the cleanrooms of the tissue bank (cleanroom of the grade A with the background of the grade B) and packed by the double-layer technique (Eva bags, Maco-Biotech, France). After the packaging was completed, the bag was placed into a metal cassette and cooled at a controlled rate of -1°C/min from +17°C to -90°C, 5 K/min till -150°C in a programmable freezer Kryo 10/16 (Planer Biomed, UK). Stored in a vapor phase of liquid nitrogen in a container Kryo-CE 10 K (Taylor -Wharton, USA) equipped with automatic filling, and continuous registration of the temperature and liquid nitrogen levels at -194°C [7]. The grafts were thawed after the 1-to 4-year period of storage.

Thawing Protocols.
Experimental work was based on investigating 10 CHIAA. CHIAA were randomly divided into two groups of five samples. All CHIAA were thawed in their unopened original packaging. Two thawing protocols were tested: protocol 1: five CHIAA thawed in a water bath at 37°C. Thawing times: minimum 3 min. 17 sec. and maximum 3 min. 30 sec. Protocol 2: five CHIAA thawed in a controlled environment at 5°C. Thawing times: minimum of 90 min and maximum of 90 min.
The identical times in both thawing protocols were given by the standardised amount of cryoprotectant used, similar length and thickness of the CHIAA. After the thawing was completed, two samples were taken from each CHIAA. The first sample was fixed in a 4% formaldehyde solution and sent for scanning electron microscope (SEM) analysis. The second sample was stored in a Celsior solution (batch CEL 0076-02) and sent for immediate testing of the mechanical properties.

Sample Preparation for Ultrastructural Analysis.
A 2 cm sample from each CHIAA from both thawing protocols was divided into 5-10 mm subsamples. Samples were mounted on convex polystyrene casts. All samples were washed in distilled water for 5 min, then dehydrated in a graded ethanol series (70, 85, 95, and 100%) for 5 min at each level. The 2.3. Testing of the Mechanical Properties. After the thawing protocols were completed, a sample from each CHIAA was collected and stored in a Custodiol® solution. Afterwards, they were sent for immediate testing of the mechanical properties. Longitudinal and circumferential samples were prepared from each tested CHIAA. These tissues were cut to stripes approximately 3 × 30 mm. Exact dimensions of individual samples were measured using a calibrated microscope camera to obtain the crossectional area and sample initial length. Testing of the mechanical properties of the CHIAA was evaluated on a custom-built uniaxial tensile testing machine. This machine consists of a servo-controlled linear stage with 3D printed tissue fixing jaws with strain sensors. Controlling was done using the NI compact DAQ (National Instruments, Austin, TX, USA) platform. The linear stage was controlled using the digital I/O module (cDAQ 9401), and a signal from the strain sensor was acquired using a universal analogue module with signal conditioning (cDAQ 9218). Custom LabVIEW software was used. Servo control was synchronized with the data acquisition sample rate. The samples' stress-strain data were measured until rupture. The ultimate tensile stress and the relative strain were evaluated.

Discussion
A prototypical CA should have anatomical and physiological properties indistinguishable from a native artery. The viscoelastic and inertial properties of the arterial wall are essential for proper arterial functional. They allow arteries to convert blood pulsatility into continuous arteriolar-capillary flow and pressure [9]. Whether these properties are affected by cryopreservation and subsequent thawing remain controversial [10].
Experimental models dealing with CA functional properties and structural damage caused by cryopreservation have been published scarcely [11]. Nevertheless, research papers dealing with similar experimental models on human CA are even rarer [12][13][14]. However, none of these papers had tried to correlate structural changes of human CA caused by thawing and their direct effect on CA mechanical Confluent endothelium with structural inhomogeneity-irregularities in the form of individual cells and changes of their membranes are detectable 3 Disruption of intercellular contacts-continuity of endothelial coverage is lost, and endotheliocytes shrink while still adhering to basal membrane 4 Separation of endothelial cells-endotheliocytes separated from the basal lamina. Initially, they protrude by their intercellular edges into the lumen 5 Complete loss of endothelium-denudation of the endothelial covering with the basal lamina exposed    BioMed Research International properties. Our experimental work tried to find the correlation between the severity of structural damage of CA that occurs during thawing and mechanical properties. Cryopreservation of vascular allografts is done in a manner that minimises the structural damage, preserves structural integrity, and aims to maintain hemodynamic properties of a native vessel [15]. Karls-son et al. and Rigol et al. described damages caused by cryopreservation on the smooth muscle cells, elastin, and collagen fibres [16,17]. Several papers showed that after cryopreservation of arteries affects their reactivity, the endothelial integrity and function are impaired [9,18]. Our experimental work showed that the severity of structural damage could be correlated to the rate of thawing. CA thawed at slower thawing protocol showed much lower structural damage when compared to CA thawed at a higher rate.
A crucial concern in the use of CA is their potential dilatation, aneurysm formation, and eventual rupture caused by structural damage which caused during thawing. Furthermore, this can alter the CA viscoelastic and inertial properties. Shahmansouri et al. demonstrated that fresh allografts (FA) showed 20% higher toughness than CA, demonstrating the effect of cryopreservation on mechanical properties, thus adversely affecting the toughness properties of the CA [15]. Their work showed that the variations in wall damping could cause changes in the strain and stress in the arterial wall [15].

BioMed Research International
Kubikova et al. showed the wave-like organisation of collagen in arteries, contributing to tissue mechanical properties only at higher values of the deformation after its alignment in the loading direction. The initial phase of loading the material properties of collagen only marginally influences the modulus of elasticity of tissue [19]. Other aspects that may increase the risk of rupture by creating increased localised wall stress are arterial calcifications [19]. However, intimal calcifications are regularly found in the context of an atherosclerotic alteration of the vessel wall. Their role in an increased risk of rupture is not well understood. Our experimental results showed that the biomechanical properties of CA were not significantly affected by the rate of thawing. Although, due to our small sample size, we cannot draw a strong conclusion, and more testing is required.
The biggest limitation of our experimental work is the small number of CHIAA used for ultrahistological analysis. Also, the technical aspect of the mechanical property testing of the CHIAA did not allowed us to provide the modulus elastic values.

Conclusion
Human arterial allografts are very rarely available for the experimental work. The cryopreservation protocol used by our tissue bank preserves the biomechanical properties of vascular allografts despite the rate of thawing. Slow thawing of vascular allografts greatly reduces the structural damage caused by cryopreservation and subsequent thawing. Despite the significant differences in structural changes of presented two thawing protocols, the ultimate tensile strain showed no statistical difference between thawing methods. This does not mean that the structural changes occurring during fast thawing do not affect the clinical performance of cryopreserved arterial allografts in other aspects.

Data Availability
All of the data is presented within the manuscript.

Conflicts of Interest
The authors declare that there is no conflict of interests regarding the publication of this article.

Authors' Contributions
RN contributed to the experiment design, results analysis, and manuscript writing. PM contributed to the experiment design, cryopreservation protocol development, results analysis, and manuscript editing. JC contributed to the manuscript editing and data collection. RM contributed to the biomechanical properties testing. TM contributed to the biomechanical properties testing. MK contributed to the allograft thawing and data collection. PI contributed to the data collection and figure preparation. LS contributed to the cryopreservation protocol development and allograft thawing. JH contributed to the histological analysis and data collection. JP contributed to the data collection, data analysis, and manuscript editing. LJ contributed to the data collection, data analysis, and manuscript editing. JF contributed to the experiment overview, experiment approval, and manuscript approval.

Funding
This research received funding from a grant NV18-02-00422.